MAGGI, FABRIZIO
 Distribuzione geografica
Continente #
NA - Nord America 16.038
AS - Asia 8.006
EU - Europa 5.846
SA - Sud America 2.213
AF - Africa 193
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 11
Totale 32.318
Nazione #
US - Stati Uniti d'America 15.793
SG - Singapore 3.009
BR - Brasile 1.784
IT - Italia 1.748
VN - Vietnam 1.699
CN - Cina 1.312
HK - Hong Kong 1.222
IE - Irlanda 881
SE - Svezia 588
DE - Germania 582
FR - Francia 531
RU - Federazione Russa 395
UA - Ucraina 373
GB - Regno Unito 313
AR - Argentina 182
FI - Finlandia 169
BD - Bangladesh 136
IN - India 130
MX - Messico 106
ID - Indonesia 100
JP - Giappone 91
CA - Canada 86
EC - Ecuador 69
IQ - Iraq 59
ZA - Sudafrica 51
NL - Olanda 45
CO - Colombia 43
PL - Polonia 40
PY - Paraguay 40
ES - Italia 33
UZ - Uzbekistan 31
AT - Austria 30
NG - Nigeria 30
CL - Cile 29
PK - Pakistan 28
MA - Marocco 26
TR - Turchia 25
VE - Venezuela 25
BE - Belgio 22
PE - Perù 21
SA - Arabia Saudita 21
EG - Egitto 18
KE - Kenya 18
LT - Lituania 17
NP - Nepal 16
UY - Uruguay 14
PH - Filippine 13
AZ - Azerbaigian 12
CZ - Repubblica Ceca 12
DZ - Algeria 12
MD - Moldavia 11
MY - Malesia 11
TN - Tunisia 11
AE - Emirati Arabi Uniti 10
JO - Giordania 10
DO - Repubblica Dominicana 9
KZ - Kazakistan 9
LB - Libano 9
AU - Australia 8
BG - Bulgaria 8
ET - Etiopia 8
IL - Israele 8
JM - Giamaica 8
OM - Oman 8
EU - Europa 7
HR - Croazia 7
RO - Romania 7
BB - Barbados 6
NI - Nicaragua 6
TH - Thailandia 6
CI - Costa d'Avorio 5
HN - Honduras 5
AL - Albania 4
BO - Bolivia 4
GT - Guatemala 4
HU - Ungheria 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
BN - Brunei Darussalam 3
BY - Bielorussia 3
CY - Cipro 3
EE - Estonia 3
GA - Gabon 3
GE - Georgia 3
GR - Grecia 3
LK - Sri Lanka 3
PA - Panama 3
QA - Qatar 3
TZ - Tanzania 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BH - Bahrain 2
BW - Botswana 2
CH - Svizzera 2
CR - Costa Rica 2
CU - Cuba 2
DM - Dominica 2
GY - Guiana 2
IR - Iran 2
KW - Kuwait 2
Totale 32.287
Città #
San Jose 1.884
Singapore 1.505
Ashburn 1.489
Fairfield 1.289
Hong Kong 1.213
Jacksonville 961
Milan 907
Dublin 864
Princeton 737
Dallas 702
Chandler 652
Wilmington 636
Woodbridge 490
Council Bluffs 478
The Dalles 467
Houston 445
Nyköping 438
Seattle 425
Boardman 410
Cambridge 381
Ho Chi Minh City 377
Lauterbourg 370
Dong Ket 334
Chicago 316
Beijing 313
Los Angeles 250
Hanoi 196
New York 194
San Diego 177
Redwood City 176
São Paulo 155
Ogden 142
Ann Arbor 138
Washington 129
Helsinki 128
Rome 117
Santa Clara 115
Salt Lake City 114
London 106
Tokyo 84
Como 70
Tampa 67
Mexico City 64
Buffalo 59
Elk Grove Village 58
Munich 58
Haiphong 57
Frankfurt am Main 56
Rio de Janeiro 52
Lancaster 49
Guangzhou 48
Norwalk 47
Orem 43
Da Nang 42
Brasília 40
Varese 40
Atlanta 35
Warsaw 35
Denver 33
Belo Horizonte 32
Shanghai 32
Chennai 30
Abuja 29
Biên Hòa 28
Brooklyn 28
Porto Alegre 28
Shenzhen 28
Nuremberg 27
San Francisco 26
Stockholm 26
Tashkent 26
Dhaka 25
Sterling 25
Hangzhou 24
Montreal 24
Phoenix 24
Baghdad 23
Curitiba 23
Guarulhos 23
Johannesburg 23
Ninh Bình 22
Poplar 22
Campinas 21
Turku 21
Miami 20
Toronto 20
Boston 19
Brussels 19
Falkenstein 19
Manchester 19
Moscow 19
Quito 19
Salvador 19
Thái Bình 19
Buenos Aires 18
Can Tho 18
Guayaquil 18
Kilburn 18
Ribeirão Preto 18
Hải Dương 17
Totale 22.196
Nome #
Characterization of a lineage C.36 SARS-CoV-2 isolate with reduced susceptibility to neutralization circulating in Lombardy, Italy 479
Torque Teno Virus: A Promising Biomarker in Kidney Transplant Recipients 276
Previous humoral immunity to the endemic seasonal alphacoronaviruses NL63 and 229E is associated with worse clinical outcome in COVID-19 and suggests original antigenic sin 239
Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy 224
Viral hepatitis 212
A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection against HSV-1 and HSV-2 Genital Infections 210
Torque Teno virus: any pathological role in liver transplanted patients? 197
Torquetenovirus detection in exosomes enriched vesicles circulating in human plasma samples 186
Torquetenovirus DNA drives proinflammatory cytokines production and secretion by immune cells via toll-like receptor 9 181
Tyrosine kinase inhibitors play an antiviral action in patients affected by chronic myeloid leukemia: a possible model supporting their use in the fight against SARS-CoV-2 179
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation 167
Comparative evaluation of five rapid methods for identifying subtype 1b and 2c hepatitis C virus isolates 165
Multicenter Cross-sectional Study on the Epidemiology of Human Metapneumovirus in Italy, 2022–2024, With a Focus on Adults Over 50 Years of Age 163
An episode of oral mucositis after the first administration of the ChAdOx1 COVID-19 vaccine 162
Anti-SARS-CoV-2 antibody levels and kinetics of vaccine response: potential role for unresolved inflammation following recovery from SARS-CoV-2 infection 162
An Italian Multicenter Study on the Epidemiology of Respiratory Syncytial Virus During SARS-CoV-2 Pandemic in Hospitalized Children 161
Impact of Microbial Metabolites on Microbiota–Gut–Brain Ax-is in Inflammatory Bowel Disease 161
Immunobiology of the Torque teno viruses and other anelloviruses 160
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021 159
Mucosal immune response in BNT162b2 COVID-19 vaccine recipients 153
Emergence of SARS-COV-2 Spike Protein Escape Mutation Q493R after Treatment for COVID-19 149
5-HT2a inhibitors for progressive multifocal leukoencephalopathy: old drugs for an old disease 147
Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: results of a prospective cohort study of 365 patients 141
Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 2022 136
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction? 136
Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine 134
Enhanced in vitro virus expression using 3-dimensional cell culture spheroids for infection 133
Zinc Oral Supplementation Induces a Significant Rise of TRECs and T CD4+NaiVe and Prevents the Increase of Ttv Viral Load after Stem Cell Transplantation: The Zenith Study 131
Breakthrough Infections of E484K-Harboring SARS-CoV-2 Delta Variant, Lombardy, Italy 131
TTV GUIDE IT - A randomised controlled trial to compare the safety, tolerability and preliminary efficacy between standard and torque teno virus-guided immunosuppression in stable adult kidney transplant recipients with low immunological risk in the first year after transplantation - a trial protocol 131
How Current Direct-Acting Antiviral and Novel Cell Culture Systems for HCV are Shaping Therapy and Molecular Diagnosis of Chronic HCV Infection 129
Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients 129
Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy 128
Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021 128
Sialic acid moieties and 5-HT2a: two faces of the same receptor for JC virus? 126
High prevalence of TT virus (TTV) and TTV-like minivirus in cervical swabs 124
La vaccinazione con la glicoproteina B del virus Herpes Simplex tipo 1 protegge contro l’herpes genitale 123
Absence of xenotropic murine leukemia virus-related virus in italian patients affected by chronic fatigue syndrome, fibromyalgia, or rheumatoid arthritis 123
HIV-1 NAT minipool during the pre-seroconversion window period: Detection of a repeat blood donor 123
Asymptomatic SARS-CoV-2 vaccine breakthrough infections in health care workers identified through routine universal surveillance testing 123
Hyaluronan: A neuroimmune modulator in the microbiota-gut axis 120
Can interferon-ribavirin effectively treat patients who did not respond to a first conventional therapy by interferon? 119
Detection of Torquetenovirus and Redondovirus DNA in Saliva Samples from SARS-CoV-2-Positive and -Negative Subjects 117
Role of Low-Molecular-Weight Heparin in Hospitalized Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study 117
Anelloviruses and immune competence 114
Zika Virus: Implications for Public Health 114
TTV and other anelloviruses: The astonishingly wide spread of a viral infection 113
Analysis of immune escape variants from antibody‐based therapeutics against covid‐19: A systematic review 113
Genomic surveillance of SARS-CoV-2 positive passengers on flights from China to Italy, December 2022 111
5-HT2a inhibitors for progressive multifocal leukoencephalopathy: Old drugs for an old disease 111
Comparative evaluation of molecular methods for the quantitative measure of torquetenovirus (TTV) viremia, the new surrogate marker of immune competence 110
Immunosuppressive monoclonal antibodies: current and next generation 109
TT virus in the nasal secretions of children with acute respiratory diseases: Relations to viremia and disease severity 109
Imported SARS-COV-2 Variant P.1 Detected in Traveler Returning from Brazil to Italy 109
SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients 109
Sialic acid moieties and 5-HT(2a): Two faces of the same receptor for JC virus? 108
Assessment of prevalence and load of torquetenovirus viremia in a large cohort of healthy blood donors 108
Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study 108
Influence of hepatitis C virus (HCV) genotype, HCV RNA load, and alanine aminotransferase level on reduction of HCV RNA after a single administration of interferon alpha 107
A novel rolling circle amplification assay to detect members of the family Anelloviridae in pigs and humans 107
Expansion of L452R-Positive SARS-CoV-2 Omicron Variant, Northern Lombardy, Italy 107
Torquetenovirus (TTV) load is associated with mortality in Italian elderly subjects 106
Human anelloviruses and the central nervous system 105
Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution 105
JC virus DNA in healthy brain tissue: a challenge for progressive multifocal leukoencephalopathy diagnosis 104
A multidisciplinary approach to study a couple of monozygotic twins discordant for the chronic fatigue syndrome: a focus on potential salivary biomarkers 104
Attempt to classify the clinical impact of DNA viruses according to the ability to activate the innate immune system 103
Torquetenovirus infection and ciliary dysmotility in children with recurrent pneumonia 102
TT virus loads and lymphocyte subpopulations in children with acute respiratory diseases 102
Getting the most from the Ebola vaccine success 101
Human metapneumovirus associated with respiratory tract infections in a 3-year study of nasal swabs from infants in Italy 101
Anellovirus 99
In vitro sensitivity of human metapneumovirus to type i interferons 99
Xenotropic murine leukaemia virus-related virus is not found in peripheral blood cells from treatment-naive human immunodeficiency virus-positive patients 98
Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody 98
Torque teno virus (TTV) in multiple sclerosis patients with different patterns of disease 97
Anellovirus 96
Dynamics of Torque Teno virus plasma DNAemia in allogeneic stem cell transplant recipients 96
Kinetics of anti-SARS-COV2 spike protein IgG and IgA antibodies at 4°C: Implications for convalescent plasma stability 96
Anellovirus 95
Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans 95
TT virus infection of periodontal tissues: A controlled clinical and laboratory pilot study 94
Patient-blood management for COVID19 convalescent plasma therapy: relevance of affinity and donor–recipient differences in concentration of neutralizing antibodies 94
5-HT2a antagonists as a new treatment for JCV-associated progressive multifocal leukoencephalopathy 93
Expression of MxA mRNA in PBL from chronic hepatitis C patients and response to interferon-alpha therapy 93
Cell therapies for treatment of human immunodeficiency virus infection 93
Performance Assessment of the LIAISON® SARS-CoV-2 Antigen Assay On Nasopharyngeal Swabs 93
During readaptation in vivo, a tissue culture-adapted strain of feline immunodeficiency virus reverts to broad neutralization resistance at different times in individual hosts but through changes at the same position of the surface glycoprotein 92
Virome and Inflammasomes, a Finely Tuned Balance with Important Consequences for the Host Health 92
Olfactory and gustatory impairments in COVID-19 patients: role in early diagnosis and interferences by concomitant drugs 92
Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients 91
Nasal nitric oxide and nitric oxide synthase expression in primary ciliary dyskinesia 91
Hypothesis: Central nervous system delivery of cyclosporine A for therapy of progressive multifocal leukoencephalopathy 91
Low prevalence of TT virus in the cerebrospinal fluid of viremic patients with central nervous system disorders 91
Role of Hematopoietic Cells in the Maintenance of Chronic Human Torquetenovirus Plasma Viremia 91
Is a single COVID-19 vaccine dose enough in convalescents ? 91
On the lookout for influenza viruses in Italy during the 2021-2022 season: along came A(H3N2) viruses with a new phylogenetic makeup of their hemagglutinin 91
Human bocavirus in Italian patients with respiratory diseases 90
Lack of Marseillevirus DNA in immunocompetent and immunocompromised Italian patients 90
Early Post-Transplant Torquetenovirus Viremia Predicts Cytomegalovirus Reactivations In Solid Organ Transplant Recipients 90
Totale 12.706
Categoria #
all - tutte 188.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 188.772


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021920 0 0 0 0 0 0 0 0 0 0 0 920
2021/20222.921 242 386 65 113 52 129 181 231 165 574 297 486
2022/20232.586 442 148 149 151 81 638 30 256 370 195 58 68
2023/20242.847 233 234 256 569 574 483 49 79 216 46 17 91
2024/20255.308 19 39 885 102 64 381 98 166 624 375 811 1.744
2025/202613.838 669 800 1.411 2.889 731 357 2.449 980 1.709 894 600 349
Totale 32.991